Elucidation of the effect of Lacticaseibacillus paracasei Shirota strain (LcS) in human intestine

Not Applicable

Recruiting

• Conditions: /A; N/A

• Registration Number: JPRN-jRCTs021220028
• Lead Sponsor: Chinda Daisuke

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-17
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 10

Inclusion Criteria

Healthy men over 20 years old

Exclusion Criteria

Subjects with milk and / or soy allergies.
Subjects who refused to participate.
Subjects with a history of gastrointestinal surgery Subjects with oral medication due to a previous ill ness who refused to participate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gene expression in host cells of the intestinal mucosa

Secondary Outcome Measures

Name	Time	Method
1)LcS gene expression in intestinal contents<br>2)Microspatial analysis of LcS in feces, intestinal contents, and mucosal scraped samples<br>3)Bacterial flora composition in feces, intestinal contents, and mucosal scraped samples<br>4)Organic acid concentration in feces and intestinal contents